perindopril has been researched along with Ventricular Dysfunction, Left in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.41) | 18.2507 |
| 2000's | 21 (77.78) | 29.6817 |
| 2010's | 4 (14.81) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Gao, F; Hao, P; Liu, Y; Yang, J; Zhang, C; Zhang, K; Zhang, M; Zhang, Y | 1 |
| Das, M | 1 |
| Mikhaĭlova, NV; Morozova, TE; Vartanova, OA | 1 |
| Kanorskaia, IuS; Kanorskiĭ, SG | 1 |
| Fabiszak, T; Gierach, J; Kozinski, M; Kubica, A; Kubica, J; Magielski, P; Navarese, EP; Odrowaz-Sypniewska, G; Sukiennik, A; Swiatkiewicz, I | 1 |
| Crombie, IK; Gillespie, ND; Hutcheon, SD; McMurdo, ME; Struthers, AD | 1 |
| SoRelle, R | 1 |
| Barry, M; Cahill, J; Ledwidge, M; Maurer, B; McDonald, K; Ryan, E; Ryder, M; Timmons, L; Travers, B | 1 |
| Boos, C | 1 |
| Abe, Y; Aizawa, Y; Ali, F; Hasegawa, G; Hirabayashi, K; Kodama, M; Ma, M; Nagai, Y; Naito, M; Nakazawa, M; Narasimman, G; Saito, Y; Shirai, K; Soga, M; Suresh, P; Tachikawa, H; Takahashi, T; Wahed, M; Watanabe, K; Wen, J; Yamaguchi, K | 1 |
| Liebson, PR | 1 |
| Chirkov, YY; Holmes, AS; Horowitz, JD; Martelli, JD | 1 |
| Bozhko, AA; Kanopskiĭ, SG; Staritskiĭ, AG | 1 |
| Bécane, HM; Devaux, JY; Duboc, D; Lerebours, G; Meune, C; Vaksmann, G | 1 |
| Sanders, SP | 1 |
| Bozhko, AA; Kanorskiĭ, SG; Staritskiĭ, AG | 1 |
| Arutiunov, GP; Belenkov, IuN; Glezer, MG; Matrynov, AI; Moiseev, VS; Pozdniakov, IuM; Storozhakov, GI; Striuk, RI; Tereshchenko, SN; Zadionchenko, VM | 1 |
| Bernocchi, P; Bettini, A; Ceconi, C; Ferrari, R; Gimbatti, OJ; Golcea, SS; Papa, K | 1 |
| Garnier, A; Geny, B; Mettauer, B; Monassier, L; N'Guessan, B; Piquard, F; Veksler, V; Ventura-Clapier, R; Zoll, J | 1 |
| Korantzopoulos, P; Patsouras, D; Siogas, K | 1 |
| Arnal, JF; Michel, JB; Nicolletti, A | 1 |
| Gallois, H; Haïat, R; Hanania, G; Piot, O | 1 |
| Crijns, HJ; Tuininga, YS; van Gelder, IC; van Veldhuisen, DJ; Wiesfeld, AC | 1 |
| Francis, GS; Gassler, JP | 1 |
| Fujii, H; Harada, E; Ito, T; Mizuno, Y; Nakamura, S; Nakao, K; Nakayama, M; Ogawa, H; Saito, Y; Sakamoto, T; Shimasaki, Y; Yamamoto, N; Yasue, H; Yoshimura, M | 1 |
| Blanksma, PK; Boomsma, F; Crijns, HJ; Siebelink, HM; Vaalburg, W; van den Heuvel, AF; van Veldhuisen, DJ; van Wijk, LM | 1 |
1 review(s) available for perindopril and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
[Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].
Topics: Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Coronary Disease; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Risk Factors; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Remodeling | 2005 |
10 trial(s) available for perindopril and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Double-Blind Method; Exercise Test; Female; Follow-Up Studies; Humans; Male; Perindopril; Prospective Studies; Quality of Life; Ventricular Dysfunction, Left; Walking | 2002 |
Is multidisciplinary care of heart failure cost-beneficial when combined with optimal medical care?
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Cost-Benefit Analysis; Decision Making; Digoxin; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Health Care Costs; Heart Failure; Hospitalization; Humans; Ireland; Length of Stay; Male; Middle Aged; Perindopril; Prospective Studies; Time Factors; Ventricular Dysfunction, Left | 2003 |
Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Child; Child Welfare; Disease Progression; Double-Blind Method; Follow-Up Studies; Humans; Muscular Dystrophy, Duchenne; Perindopril; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2005 |
[Dynamics of postinfarction left ventricular remodeling during long term use of perindopril, amiodarone, and beta-adrenoblockers].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Perindopril; Retrospective Studies; Stroke Volume; Time Factors; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Remodeling | 2005 |
[Randomized multicenter study PRESTIGE: assessment of efficacy of perindopril as compared with captopril in patients with acute myocardial infarction with left ventricular dysfunction].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Humans; Male; Myocardial Infarction; Perindopril; Ventricular Dysfunction, Left | 2005 |
Blood pressure response to the first 36 hours of heart failure therapy with perindopril versus captopril. French General Hospitals National College of Cardiologists.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Echocardiography; Female; Heart Failure; Humans; Hypertension; Hypotension, Orthostatic; Indoles; Male; Myocardial Ischemia; Patient Dropouts; Perindopril; Time Factors; Ventricular Dysfunction, Left | 1999 |
Electrophysiological changes of angiotensin-converting enzyme inhibition after myocardial infarction.
Topics: Action Potentials; Angiotensin-Converting Enzyme Inhibitors; Cardiac Pacing, Artificial; Double-Blind Method; Electrocardiography; Humans; Myocardial Infarction; Perindopril; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Remodeling | 2000 |
A comparative study of the first dose hypotensive effects of captopril and perindopril in patients with heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Female; Heart Failure; Humans; Hypotension; Male; Middle Aged; Perindopril; Ventricular Dysfunction, Left | 2001 |
Effects of perindopril on aldosterone production in the failing human heart.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Cardiac Catheterization; Female; Heart Failure; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Perindopril; Statistics as Topic; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
Impairment of myocardial blood flow reserve in patients with asymptomatic left ventricular dysfunction: effects of ACE-inhibition with perindopril.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Flow Velocity; Exercise Test; Female; Humans; Male; Middle Aged; Myocardium; Natriuretic Peptide, Brain; Netherlands; Neurotransmitter Agents; Perindopril; Tomography, Emission-Computed; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
16 other study(ies) available for perindopril and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Combination of angiotensin-(1-7) with perindopril is better than single therapy in ameliorating diabetic cardiomyopathy.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Blood Glucose; Cardiomegaly; Cell Communication; Cell Differentiation; Cell Proliferation; Collagen; Diabetic Cardiomyopathies; Disease Models, Animal; Drug Therapy, Combination; Echocardiography; Fibroblasts; Fibrosis; Heart Ventricles; Hemodynamics; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Peptidyl-Dipeptidase A; Perindopril; Phosphorylation; Rats; Receptors, Angiotensin; Transforming Growth Factor beta1; Ventricular Dysfunction, Left | 2015 |
Small benefits in trastuzumab-related cardiotoxicity.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Agents, Immunological; Bisoprolol; Breast Neoplasms; Cardiotoxicity; Female; Humans; Perindopril; Randomized Controlled Trials as Topic; Stroke Volume; Time Factors; Trastuzumab; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2017 |
[Possibilities of correction of coronary and myocardial reserves in patients with ischemic heart disease by Angiotensin converting enzyme inhibitor perindopril].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Coronary Disease; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Myocardial Infarction; Perindopril; Russia; Severity of Illness Index; Ventricular Dysfunction, Left | 2008 |
[Atrial fibrillation in patients with type 2 diabetes mellitus: specific features of development and antirecurrence therapy].
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Atrial Fibrillation; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Diabetic Neuropathies; Drug Monitoring; Female; Heart Conduction System; Heart Failure, Diastolic; Humans; Male; Middle Aged; Perindopril; Random Allocation; Secondary Prevention; Sotalol; Thioctic Acid; Treatment Outcome; Ventricular Dysfunction, Left | 2010 |
Usefulness of C-reactive protein as a marker of early post-infarct left ventricular systolic dysfunction.
Topics: Aged; Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Antihypertensive Agents; Aspirin; Biomarkers; C-Reactive Protein; Clopidogrel; Female; Heparin; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Perindopril; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Ticlopidine; Ventricular Dysfunction, Left | 2012 |
Recent clinical trial updates.
Topics: Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Clinical Trials as Topic; Enalapril; Humans; Perindopril; Protease Inhibitors; Pyridines; Stroke; Thiazepines; Ventricular Dysfunction, Left | 2002 |
The EUROPA trial.
Topics: Angiotensin-Converting Enzyme Inhibitors; Coronary Disease; Echocardiography; Humans; Perindopril; Ramipril; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome; Ventricular Dysfunction, Left | 2003 |
Comparative effects of perindopril with enalapril in rats with dilated cardiomyopathy.
Topics: Administration, Oral; Angiotensin I; Animals; Cardiomyopathy, Dilated; Collagen Type III; Disease Models, Animal; Dose-Response Relationship, Drug; Enalapril; Endomyocardial Fibrosis; Gene Expression; Heart Failure; Hemodynamics; Hypertension; Infusions, Intravenous; Male; Pericardial Effusion; Perindopril; Rats; Rats, Inbred Lew; RNA, Messenger; Survival Rate; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Dysfunction, Left; Ventricular Pressure | 2003 |
VALIANT and EUROPA.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Coronary Disease; Double-Blind Method; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2004 |
Effect of perindopril on platelet nitric oxide resistance in patients with chronic heart failure secondary to ischemic left ventricular dysfunction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cyclic GMP; Female; Heart Failure; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Perindopril; Platelet Aggregation; Platelet Function Tests; Superoxides; Time Factors; Ventricular Dysfunction, Left | 2004 |
[Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Atenolol; Baroreflex; Bisoprolol; Carbazoles; Carvedilol; Data Interpretation, Statistical; Death, Sudden, Cardiac; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Perindopril; Phenylephrine; Propanolamines; Time Factors; Ventricular Dysfunction, Left | 2004 |
Did they lower stress in the trial? Or was it just wasted energy?
Topics: Angiotensin-Converting Enzyme Inhibitors; Disease Progression; Humans; Muscular Dystrophy, Duchenne; Perindopril; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Function, Left | 2005 |
ACE inhibition prevents myocardial infarction-induced skeletal muscle mitochondrial dysfunction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; GA-Binding Protein Transcription Factor; Male; Mitochondria, Muscle; Muscle, Skeletal; Myocardial Infarction; Oxygen Consumption; Peptidyl-Dipeptidase A; Perindopril; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats; Rats, Wistar; RNA-Binding Proteins; RNA, Messenger; Transcription Factors; Ventricular Dysfunction, Left | 2006 |
Transient ischemic attack and electrocardiographic abnormalities revealing left ventricular noncompaction.
Topics: Acenocoumarol; Adult; Carbazoles; Carvedilol; Diagnosis, Differential; Electrocardiography; Heart Ventricles; Humans; Ischemic Attack, Transient; Magnetic Resonance Imaging; Magnetoencephalography; Male; Perindopril; Propanolamines; Tomography, X-Ray Computed; Ventricular Dysfunction, Left | 2007 |
Left ventricular remodelling following experimental myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Atrial Natriuretic Factor; Collagen; Cyclic GMP; Hypertrophy, Left Ventricular; Indoles; Isoenzymes; Kidney; Myocardial Infarction; Myocardium; Myosins; Perindopril; Rats; Rats, Wistar; Renin; Vasopressins; Ventricular Dysfunction, Left | 1995 |
What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Indoles; Isoquinolines; Myocardial Infarction; Perindopril; Prodrugs; Quinapril; Ramipril; Stroke; Stroke Volume; Tetrahydroisoquinolines; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |